Countries in the Caribbean Region have expressed concern at the rising incidence of chronic non-communicable diseases. Cancer is one of these and the cost of treating patients with this has escalated in the recent past. In this paper, the author examines colon cancer and the cost of caring for patients with this. A viewpoint with regard to the reasons for the increase cost of care of patients with cancer is advanced. The factors contributing to the increasing costs are explored. Research epistemology and the role of the Pharmaceutical industry are also explored. The need for consensus decision-making with regard to choice of agent/regime is emphasized, as is the need for a deliberate cost-benefit approach.